Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : Semi-Equips - Buy when BLOOD is running in the streets! -- Ignore unavailable to you. Want to Upgrade?

To: Sun Tzu who wrote (8984)	11/1/2000 3:05:38 PM
From: Donald Wennerstrom	Read Replies (1) \| Respond to of 10921

On the Altera situation, Wall Street is having a tough time making up its mind on how it should be evaluated based on the following sequence of announcements, starting with the original Altera announcement last night. From Briefing.com. AFTER THE CLOSE (31-Oct-00)**** Altera (ALTR) 40 15/16 +3 15/16: Trading down 4 1/16 after hours to 36 7/8 after company guides numbers lower on its website; company says that resales in October were up 15% on July, but below management expectations, and that it now sees this quarter's sequential revenue growth at the lower end of the previous 12-15% guidance. Nov 1 - 10:00 -- 11:00 ET (Updated throughout the hour)** Altera (ALTR) 35 1/2 -5 7/16: -- Update -- Morgan Stanley Dean Witter downgrades to OUTPERFORM from STRONG BUY rating with a price target of $65. Nov 1 - 12:00 -- 13:00 ET (Updated throughout the hour)**** Altera (ALTR) 34 3/16 +15/16: -- Update -- Bear Stearns reiterates BUY rating and price target of $100. Firm is positive on the stock and does not believe that yesterday's revised estimates for the December quarter is not indicative of any fundamental change in the PLD industry and that the update is consistent with recent announcements in the communications and networking equipment markets, indicating lower but still healthy growth rates; sees shares as undervalued relative to ALTR's ability to generate strong earnings growth.